Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

More sensitive test norms better predict who might develop Alzheimer’s disease

05.01.2004


Higher cutoffs led to more accurate identification of high-functioning



Diagnosticians would do well to raise the bar when testing high-functioning people for pre-clinical signs of Alzheimer’s disease, according to a new study. Higher test cutoffs, rather than the standard group average, more accurately predicted how many highly intelligent people would deteriorate over time. This finding is reported in the January issue of Neuropsychology, which is published by the American Psychological Association (APA).

Early diagnosis of Alzheimer’s has taken on growing importance, given new medical and psychological interventions that can slow (but not stop) the course of the disease. In addition, highly intelligent people have been found, on average, to show clinical signs of Alzheimer’s later than the general population. Once they do, they decline much faster. Thought to reflect their greater mental reserves, this different pattern may call for a different approach to diagnosis.


Says lead author Dorene Rentz, PsyD, "Highly intelligent elders are often told their memory changes are typical of normal aging when they are not. As a result, they would miss the advantages of disease-modifying medications when they become available."

Rentz, of Brigham and Women’s Hospital’s Department of Neurology and Harvard Medical School, led her co-authors in a study of 42 older people with IQ’s of 120 or more, drawn from a longitudinal study of aging and Alzheimer’s Disease. Rentz and her colleagues analyzed participant performance on measures of cognitive ability, such as word generation, memory and visuospatial processing, with scores gathered at the start of the study and three-and-a-half years later. Then, they asked which of two different test norms forecast problems: The standard norm, derived from a large cross-section of the population, or an adjusted high-IQ norm that measured changes against the individual’s higher ability level?

The raised cutoffs worked better. For memory scores obtained at baseline, raised cutoffs predicted that 11 of the 42 individuals were at risk for future decline – compared with standard cutoffs, which indicated they were normal. But, what’s normal for people of average IQ isn’t normal for people of higher IQ: True to the former prediction, three and a half years later, nine of those 11 people had declined. Six of those went on to develop mild cognitive impairment (MCI), a transitional illness from normal aging to a dementia (of which one type is Alzheimer’s). Five of these individuals have since received a diagnosis of Alzheimer’s disease, two years after this study was submitted.

"With standard norms, people with higher levels of ability would be classified as normal for up to three years before they began demonstrating a decline on standardized tests," says Rentz. "In this case, they could be at risk for not receiving early treatment intervention."

The statistical approach was simple. High-IQ people were scored against an average that was "normal" for them, proportionately higher than the cross-sectional average of 100. Scores were considered abnormal if, according to standard practice, they were 1.5 standard deviations or more below the (adjusted) norm.

Rentz and her co-authors believe that by the same reasoning, adjusted norms could help people at the other end of the scale. "People with below-average intelligence have the potential for being misdiagnosed as ’demented’ when they are not, because they score below the normative cutoffs," explains Rentz. Adjusting norms to match the ability level of the person being evaluated, she believes, could have the greatest predictive power in detecting the early signs of an incipient Alzheimer’s-type dementia.

Rentz points out that for women, adjusting for IQ may be particularly useful compared with traditional adjustments for education. "Education-based methods often underestimate ability in women who did not have the same educational advantages as men, particularly in this aged cohort," she says.

The authors also report that IQ-adjusted norms might help to control for some inaccuracies that have filtered into normative data, as these norms were derived from cross-sectional populations who might not have been adequately screened for preclinical Alzheimer’s disease. Because it could take a long time to develop new databases from longitudinal studies, the authors say that the "use of an IQ-adjusted method may provide a temporary solution for clinicians and research investigators evaluating older highly intelligent individuals at risk for Alzheimer’s disease."


Article: "Use of IQ-Adjusted Norms to Predict Progressive Cognitive Decline in Highly Intelligent Older Individuals," Dorene M. Rentz, PsyD, Brigham and Women’s Hospital and Harvard Medical School; Terri J. Huh, MA, University of Massachusetts at Boston; and Robert R. Faust, B.A., Andrew E. Budson, MD, Leonard F.M. Scinto, PhD, Reisa A. Sperling, MD, and Kirk R. Daffner, MD, all of Brigham and Women’s Hospital’s Department of Neurology and Harvard Medical School; Neuropsychology, Vol. 18, No. 1.

(Full text of the article is available from the APA Public Affairs Office)

Dorene Rentz can be reached by email at drentz@partners.org or by phone at 617-732-8235. She can also be reached through a publicist, Melanie Franco, 617-534-1605 or mfranco1@partners.org. The American Psychological Association (APA), in Washington, DC, is the largest scientific and professional organization representing psychology in the United States and is the world’s largest association of psychologists. APA’s membership includes more than 150,000 researchers, educators, clinicians, consultants and students. Through its divisions in 53 subfields of psychology and affiliations with 60 state, territorial and Canadian provincial associations, APA works to advance psychology as a science, as a profession and as a means of promoting human welfare.

Pam Willenz | EurekAlert!
Further information:
http://www.apa.org/

More articles from Health and Medicine:

nachricht Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>